When Do Two Ingredients Need to Be Kept Apart in One Capsule?: Understanding Ingredient Compatibility in Multi-Phase Formulations

By: Agnivesh
September 11, 2026
0 Comments

When Do Two Ingredients Need to Be Kept Apart in One Capsule?: Understanding Ingredient Compatibility in Multi-Phase Formulations

Combining two active ingredients within one dosage form seems conceptually easy – combine ingredients, fill capsule, achieve designated dose. However, not all combinations function in this fashion. When components interact such as in phase transitions, moisture migration between phases, or one component catalytically increases the degradation rate of another; then having such components in direct contact with each other will alter one or more components potency, stability, physical appearance or shelf-life.

This becomes ingredient compatibility during formulation of a nutraceutical product which becomes a crucial consideration in dosage-form design.

An approach such as the capsule-in-capsule where two active ingredients may be physically divided while maintaining the intended single dosage form formulation. The ultimate factor for separation is through compatibility testing and one should never presuppose that all combinations need to be separated.

This blog will guide more about multi phase formulation of capsules.

Why Can't Some Nutraceutical Ingredients Simply Be Blended Together?

Ingredients react with each other via various means such as, interaction through moisture transport, oxidation, chemical interactions, and physical changes. A frequent one that is encountered is a lipophilic or an oil-based active material combined with a moisture-sensitive or hygroscopic powder. Due to the direct contact, the moisture-sensitive powder may end up immersed in a liquid medium wherein it experiences changes in the physical properties or degradation rate.

Additionally, oxidative-sensitive ingredients should be protected against oxidation or reactive substances.

During stability testing we are looking for factors such as temperature, humidity, oxidation, light since these factors hasten degradation. Therefore a poorly compatible active ingredient supplement will not have a visible effect immediately post manufacturing. The effect of the incompatible interactions will only be expressed during storage.

Warning Signs of an Ingredient Compatibility Problem

Some of the oils and lipid components are prone to oxidation. If the oil has oxidation prone components then heat, oxygen, light or other reactive materials can cause breakdown. This might be especially apparent if the oil phase is being added directly to powders with potentiallyreactive ingredients or even moisture. The objective may be to not prevent the reaction of all oils and powders, but rather understand if there is enough of an issue that it is measured as an instability.

Hygroscopic powders are capable of picking up water from their environment. An liquid phase in a formulation or a capsule shell with high water may also deliver moisture to a formulation with sensitive ingredients causing both physical and chemical instability. Moisture is one component in assessing stability of pharmaceuticals, especially when compounds undergo hydrolysis or physical degradation. This is why an oil and powder separated capsule may be considered when separation would allow both components to remain stable with an unacceptable degree of stability between both components

Problems in compatibility don’t have to manifest as vigorous chemical reaction.

During development or stability testing the formulator might notice:

– Change in active potency

– Appearance of degradation products

– Change in colour

– Change in odor

– Powdery clumps/ agglomeration

– Change in fill viscosity

– Shell bursting/ leaking, shell integrity problems

A change observed in a stability study does not automatically prove two actives are incompatible, but it is a notification that investigation should be considered.

How Is Ingredient Compatibility Actually Tested?

Tests should be conducted to verify compatibility of any new materials before choosing a novel capsule system. Often a form team will review each proposed ingredient and combinations of the ingredients, as well as their phys chem characteristics. Depending on the form this could involve some stress or accelerated testing, moisture exposure, assessment of any oxidation occurring, as well as physically looking at the material and analysis to check the active content and degradation.

When Is a Multi-Phase Capsule the Right Choice?

Not all combination products necessitate a high-tech capsule form. Any combination can be formulated with a traditional capsule where stability data supports that they will not interact and the formulation will hold its specifications over the designed shelf life. The capsule-in-capsule ingredient approach really starts to apply: When two ingredients demonstrate an observable interaction in a combination formulation.

When it is necessary to separate an oil and a powder?

When it is necessary to protect a moisture-sensitive ingredient from a different phase of the formula. When it is necessary to deliver a formula in two separate release stages. When two formulations need two distinct excipient systems. When a brand requires two discrete phases of delivery inside a single unit dose.

Capsule in capsule allows us to deliver combinations that would otherwise separate physically, but remain as a single dose, like in a powder oil capsule in capsule.

The key is that separation be a formulation challenge rather than solely a marketing challenge.

What Should You Bring to a Compatibility Discussion?

Prior to your discussions with a formulation or manufacturing team: Have this information ready;
Ingredient list – A full list of ingredients including all active components, extracts, oils, excipients and percentage of these.
Known potential stability problems – “We know that this ingredient tends to be sensitive to moisture, oxidation, light and temperature.”
Target shelf life and storage conditions – the required duration for which the supplement must remain within specification.
Desired release profile – “Do you need to release the ingredients over the same period or at different times?”
Capsule preference – What is your target capsule material and size, is there a requirement for vegetarian or vegan, and other branding factors.
Any available stability information- The results from the lab, or from pilot batches. Are any of these indicating any changes in potency, colour, or odour?
Once the formulation team receives these details, they can decide whether it is feasible for a simple blend, a “separate fill” or the use of a more complicated multi-phase form.

Build the right choice around your formulation

When two activities aren’t suitable for combination then one is not the obvious one to withdraw from your formulation. Often a physically separated formulation would still allow the two actives within a single dosage unit but limiting interactions, allowing for separate release characteristics of the two actives. The correct technique comes from a formulation assessment of ingredient compatibility nutraceutical followed by appropriate storage and a suitable capsule architecture. When two activities are not suitable for combination, our team can conduct a compatibility test on your form before you decide what formulation you should create around them.

FAQs

Q1. Is a multi-phase capsule required in every combination product?

No. When compatability and stability studies show that ingredients are acceptable to co-exist with limited degradative effects, a simple capsule would suffice.

Q2. How long is compatibility testing carried out for?

There is no set rule. This is dependent on formulation, test design, analytical methods, storage conditions, developmental stage etc. While initial screening is helpful, long-term stability studies take significantly longer.

Q3. Are compatibility problems sometimes observed only after several months?

Yes. While degradation can occur as and when it’s triggered, it can also occur over prolonged periods of time to reach a significant measurement.

Q4. Are the techniques of capsule-in-capsule formulation and an enteric coat the same?

No. These methods allow for different formulation outcomes. Capsule-in-capsule is about separating two formulations within a single dosage form, unlike an enteric coat that is usually formulated to delay absorption once within an environment to which it is appropriate for.